Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database.

Emery, Corinne; Torreton, Elodie; Dejager, Sylvie; Levy-Bachelot, Laurie; Bineau, Sébastien; Detournay, Bruno

Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database.

Emery, Corinne; Torreton, Elodie; Dejager, Sylvie; Levy-Bachelot, Laurie; Bineau, Sébastien; Detournay, Bruno.

Afiliación

Emery C; Cemka, 43, boulevard Maréchal Joffre, 92 340, Bourg la Reine, France.
Torreton E; Cemka, 43, boulevard Maréchal Joffre, 92 340, Bourg la Reine, France.
Dejager S; Laboratoires MSD France, 10-12 Cours Michelet, 92800, Puteaux, France.
Levy-Bachelot L; Laboratoires MSD France, 10-12 Cours Michelet, 92800, Puteaux, France.
Bineau S; Laboratoires MSD France, 10-12 Cours Michelet, 92800, Puteaux, France.
Detournay B; Cemka, 43, boulevard Maréchal Joffre, 92 340, Bourg la Reine, France. bruno.detournay@cemka.fr.

Diabetes Ther ; 11(2): 535-548, 2020 Feb.

Article en En | MEDLINE | ID: mdl-31953694

Palabras clave

Budget impact; Claim database; Costs; DPP4I; Diabetes; Time series analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Observational_studies / Risk_factors_studies Idioma: En Revista: Diabetes Ther Año: 2020 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google